

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | natural killer cell activation involved in immune response (GO:0002323) | 7.38780132 |
| 2 | * positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 7.17528278 |
| 3 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 7.04109681 |
| 4 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 7.04109681 |
| 5 | * regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 6.47277513 |
| 6 | regulation of T-helper 1 cell differentiation (GO:0045625) | 6.38147684 |
| 7 | * positive regulation of T-helper cell differentiation (GO:0045624) | 6.19984648 |
| 8 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.17910582 |
| 9 | regulation of chronic inflammatory response (GO:0002676) | 5.96664123 |
| 10 | * regulation of activation of Janus kinase activity (GO:0010533) | 5.54421091 |
| 11 | * positive regulation of T-helper 1 type immune response (GO:0002827) | 5.44653385 |
| 12 | cellular response to exogenous dsRNA (GO:0071360) | 5.29116253 |
| 13 | regulation of fever generation (GO:0031620) | 4.84151347 |
| 14 | response to protozoan (GO:0001562) | 4.78167741 |
| 15 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.75747593 |
| 16 | positive regulation of heat generation (GO:0031652) | 4.67698396 |
| 17 | * regulation of T-helper cell differentiation (GO:0045622) | 4.64007600 |
| 18 | * positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.61324690 |
| 19 | regulation of response to tumor cell (GO:0002834) | 4.59400724 |
| 20 | positive regulation of response to tumor cell (GO:0002836) | 4.59400724 |
| 21 | positive regulation of immune response to tumor cell (GO:0002839) | 4.59400724 |
| 22 | regulation of immune response to tumor cell (GO:0002837) | 4.59400724 |
| 23 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.58372933 |
| 24 | response to peptidoglycan (GO:0032494) | 4.57452798 |
| 25 | * positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 4.43531621 |
| 26 | * regulation of memory T cell differentiation (GO:0043380) | 4.34725486 |
| 27 | negative regulation of interleukin-17 production (GO:0032700) | 4.33791476 |
| 28 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.32889552 |
| 29 | adhesion of symbiont to host cell (GO:0044650) | 4.30691222 |
| 30 | virion attachment to host cell (GO:0019062) | 4.30691222 |
| 31 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.25213458 |
| 32 | T-helper 1 type immune response (GO:0042088) | 4.22449726 |
| 33 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.15944444 |
| 34 | * regulation of T-helper 1 type immune response (GO:0002825) | 4.15645042 |
| 35 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.13409994 |
| 36 | cellular response to interferon-beta (GO:0035458) | 4.13285162 |
| 37 | * positive regulation of interleukin-17 production (GO:0032740) | 4.12045063 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 4.07796808 |
| 39 | * positive regulation of natural killer cell activation (GO:0032816) | 3.95833858 |
| 40 | negative regulation of type 2 immune response (GO:0002829) | 3.93726098 |
| 41 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.90316301 |
| 42 | fatty acid elongation (GO:0030497) | 3.87362587 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.87114222 |
| 44 | * positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.84374336 |
| 45 | T-helper cell differentiation (GO:0042093) | 3.83680717 |
| 46 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.83680717 |
| 47 | central nervous system myelination (GO:0022010) | 3.83376463 |
| 48 | axon ensheathment in central nervous system (GO:0032291) | 3.83376463 |
| 49 | negative regulation of growth of symbiont in host (GO:0044130) | 3.83206684 |
| 50 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.83206684 |
| 51 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.83206684 |
| 52 | regulation of growth of symbiont in host (GO:0044126) | 3.83206684 |
| 53 | regulation of T cell cytokine production (GO:0002724) | 3.79352361 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.74487416 |
| 55 | regulation of heat generation (GO:0031650) | 3.73668100 |
| 56 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.72679898 |
| 57 | positive regulation of interleukin-2 production (GO:0032743) | 3.70964593 |
| 58 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.70018954 |
| 59 | response to interferon-beta (GO:0035456) | 3.69859869 |
| 60 | Rap protein signal transduction (GO:0032486) | 3.68443636 |
| 61 | leukocyte aggregation (GO:0070486) | 3.67995060 |
| 62 | * positive regulation of interleukin-12 production (GO:0032735) | 3.67873077 |
| 63 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.64747285 |
| 64 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.63892671 |
| 65 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.58730146 |
| 66 | * regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.58583242 |
| 67 | response to hepatocyte growth factor (GO:0035728) | 3.58488939 |
| 68 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.58488939 |
| 69 | positive regulation of actin filament depolymerization (GO:0030836) | 3.56988517 |
| 70 | * regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.56829154 |
| 71 | * regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.54140847 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 3.51662183 |
| 73 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.47378964 |
| 74 | T cell differentiation involved in immune response (GO:0002292) | 3.46788833 |
| 75 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.46788833 |
| 76 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.46788833 |
| 77 | positive regulation of isotype switching (GO:0045830) | 3.46366922 |
| 78 | * positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.42025562 |
| 79 | * regulation of interleukin-12 production (GO:0032655) | 3.41369440 |
| 80 | response to muramyl dipeptide (GO:0032495) | 3.39559621 |
| 81 | * positive regulation of activated T cell proliferation (GO:0042104) | 3.39515714 |
| 82 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.38987222 |
| 83 | regulation of podosome assembly (GO:0071801) | 3.36594348 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34001128 |
| 85 | * regulation of interleukin-17 production (GO:0032660) | 3.33475776 |
| 86 | adhesion of symbiont to host (GO:0044406) | 3.32391663 |
| 87 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.32031864 |
| 88 | * regulation of natural killer cell activation (GO:0032814) | 3.31542702 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 3.30658681 |
| 90 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.29452782 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.28899014 |
| 92 | cellular response to type I interferon (GO:0071357) | 3.28536041 |
| 93 | type I interferon signaling pathway (GO:0060337) | 3.28536041 |
| 94 | regulation of type 2 immune response (GO:0002828) | 3.28476630 |
| 95 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.27706236 |
| 96 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.27706236 |
| 97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.26498252 |
| 98 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.24512268 |
| 99 | axon ensheathment (GO:0008366) | 3.23885154 |
| 100 | ensheathment of neurons (GO:0007272) | 3.23885154 |
| 101 | myelination (GO:0042552) | 3.23635112 |
| 102 | response to type I interferon (GO:0034340) | 3.22837721 |
| 103 | * positive regulation of defense response to virus by host (GO:0002230) | 3.22324128 |
| 104 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.21562454 |
| 105 | positive regulation of lymphocyte migration (GO:2000403) | 3.21378721 |
| 106 | regulation of chemokine biosynthetic process (GO:0045073) | 3.18213785 |
| 107 | negative regulation of amino acid transport (GO:0051956) | 3.16049839 |
| 108 | regulation of vitamin metabolic process (GO:0030656) | 3.15838793 |
| 109 | regulation of isotype switching (GO:0045191) | 3.15312834 |
| 110 | regulation of regulatory T cell differentiation (GO:0045589) | 3.13692534 |
| 111 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.12319936 |
| 112 | * positive regulation of interferon-gamma production (GO:0032729) | 3.12076987 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 3.11872335 |
| 114 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.09123799 |
| 115 | cholesterol biosynthetic process (GO:0006695) | 3.08548175 |
| 116 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.08287768 |
| 117 | defense response to protozoan (GO:0042832) | 3.07930967 |
| 118 | * negative regulation of interleukin-10 production (GO:0032693) | 3.07102452 |
| 119 | positive regulation of DNA recombination (GO:0045911) | 3.05766957 |
| 120 | * regulation of defense response to virus by host (GO:0050691) | 3.03377517 |
| 121 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.99825906 |
| 122 | positive regulation of acute inflammatory response (GO:0002675) | 2.99672940 |
| 123 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.99611688 |
| 124 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99181136 |
| 125 | detection of other organism (GO:0098543) | 2.98565437 |
| 126 | negative regulation by host of viral transcription (GO:0043922) | 2.96983737 |
| 127 | regulation of immunoglobulin secretion (GO:0051023) | 2.96844311 |
| 128 | positive regulation of B cell mediated immunity (GO:0002714) | 2.94852702 |
| 129 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.94852702 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.91542381 |
| 131 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.91104467 |
| 132 | sexual reproduction (GO:0019953) | 2.90307132 |
| 133 | * regulation of T cell mediated immunity (GO:0002709) | 2.83054242 |
| 134 | myeloid dendritic cell differentiation (GO:0043011) | 2.82975696 |
| 135 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.82749001 |
| 136 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.82749001 |
| 137 | regulation of antigen processing and presentation (GO:0002577) | 2.82489662 |
| 138 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.79488079 |
| 139 | eosinophil migration (GO:0072677) | 2.77836836 |
| 140 | * regulation of NF-kappaB import into nucleus (GO:0042345) | 2.75546904 |
| 141 | lymphocyte chemotaxis (GO:0048247) | 2.73784592 |
| 142 | negative regulation of viral genome replication (GO:0045071) | 2.72645451 |
| 143 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.72135397 |
| 144 | superoxide anion generation (GO:0042554) | 2.71651272 |
| 145 | T cell activation involved in immune response (GO:0002286) | 2.67330763 |
| 146 | * positive regulation of interleukin-10 production (GO:0032733) | 2.65291810 |
| 147 | positive regulation of interferon-alpha production (GO:0032727) | 2.64792616 |
| 148 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.61855902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.71647303 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.19747358 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.00793719 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.74796097 |
| 5 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.37546842 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.30399109 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87594681 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61216342 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.56539834 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48839766 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47556869 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.46160166 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.31702764 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19507219 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.17891371 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11870703 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.11486803 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10894913 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04109683 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96201760 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95025273 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.94271149 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93129897 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 1.86248154 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85629494 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84394206 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83787469 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83467104 |
| 29 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.81280120 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79327611 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75717449 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.74915022 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73527425 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70910579 |
| 35 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70662045 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.70546817 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70398845 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69453118 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68659534 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67239224 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66253206 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60552352 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60096141 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.59884475 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57302014 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57038668 |
| 47 | GATA3_26560356_Chip-Seq_TH2_Human | 1.56809274 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56295960 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.54098517 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50960434 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48181432 |
| 52 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.47168699 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.42292984 |
| 54 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41555569 |
| 55 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41537444 |
| 56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.40928479 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40120767 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34868764 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34008754 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.33773242 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33305542 |
| 62 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32850185 |
| 63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29920110 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29785515 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29053930 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28983048 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28289561 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28289561 |
| 69 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28155325 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27454027 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26779234 |
| 72 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.26266258 |
| 73 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.26177877 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25622405 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24949297 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24613585 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22279694 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20072653 |
| 79 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.19956476 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19663594 |
| 81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18983514 |
| 82 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17535992 |
| 83 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17535992 |
| 84 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17535992 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16128663 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15510725 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15223420 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14786637 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13468489 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13069837 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12829875 |
| 92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12344522 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11716774 |
| 94 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11331852 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11260067 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11047620 |
| 97 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11028147 |
| 98 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09952947 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09455236 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09169146 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08803040 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08772347 |
| 103 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07818101 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07283519 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07242600 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06597817 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06169589 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05642274 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05544294 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05019488 |
| 111 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03886590 |
| 112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03877904 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02828047 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02717951 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01294242 |
| 116 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.01095786 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00470920 |
| 118 | CJUN_26792858_Chip-Seq_BT549_Human | 1.00456753 |
| 119 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00271213 |
| 120 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00089879 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99968064 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99925549 |
| 123 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97827422 |
| 124 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97121444 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96983095 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96929199 |
| 127 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96298777 |
| 128 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95366632 |
| 129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94825041 |
| 130 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94730019 |
| 131 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94614296 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94120018 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93897115 |
| 134 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93829976 |
| 135 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91598825 |
| 136 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91552505 |
| 137 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90476320 |
| 138 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90275785 |
| 139 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90199782 |
| 140 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90124109 |
| 141 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89119786 |
| 142 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88996623 |
| 143 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88737279 |
| 144 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88641287 |
| 145 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.88297394 |
| 146 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88250189 |
| 147 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.88191684 |
| 148 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.87288008 |
| 149 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87234518 |
| 150 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86332625 |
| 151 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86326253 |
| 152 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.86270055 |
| 153 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86227252 |
| 154 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85984923 |
| 155 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85683256 |
| 156 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85649079 |
| 157 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.84869479 |
| 158 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84143573 |
| 159 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84019861 |
| 160 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84008786 |
| 161 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83934883 |
| 162 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83813209 |
| 163 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83537614 |
| 164 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83464847 |
| 165 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83463359 |
| 166 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82959709 |
| 167 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82655120 |
| 168 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81263648 |
| 169 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81227799 |
| 170 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80673372 |
| 171 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80673372 |
| 172 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.79719305 |
| 173 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79626965 |
| 174 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.79318646 |
| 175 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.79318646 |
| 176 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77209920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 6.26939634 |
| 2 | * MP0009785_altered_susceptibility_to | 4.07851656 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.79567708 |
| 4 | MP0000920_abnormal_myelination | 3.70989940 |
| 5 | MP0003690_abnormal_glial_cell | 3.61651352 |
| 6 | MP0002254_reproductive_system_inflammat | 3.53432677 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.52721554 |
| 8 | MP0003724_increased_susceptibility_to | 3.06290310 |
| 9 | MP0000685_abnormal_immune_system | 2.78461874 |
| 10 | * MP0005000_abnormal_immune_tolerance | 2.73305707 |
| 11 | MP0001348_abnormal_lacrimal_gland | 2.71843557 |
| 12 | MP0001346_abnormal_lacrimal_gland | 2.67053310 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.64694124 |
| 14 | * MP0005025_abnormal_response_to | 2.51725262 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.49450914 |
| 16 | MP0005310_abnormal_salivary_gland | 2.33601871 |
| 17 | * MP0002419_abnormal_innate_immunity | 2.28750889 |
| 18 | MP0005671_abnormal_response_to | 2.26438931 |
| 19 | MP0009764_decreased_sensitivity_to | 2.17422683 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 2.12554524 |
| 21 | MP0003763_abnormal_thymus_physiology | 1.94576683 |
| 22 | MP0008057_abnormal_DNA_replication | 1.91792131 |
| 23 | MP0003880_abnormal_central_pattern | 1.86962967 |
| 24 | MP0001790_abnormal_immune_system | 1.80951347 |
| 25 | MP0005387_immune_system_phenotype | 1.80951347 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.80689840 |
| 27 | * MP0002723_abnormal_immune_serum | 1.80484174 |
| 28 | MP0004510_myositis | 1.79676194 |
| 29 | MP0005451_abnormal_body_composition | 1.77953500 |
| 30 | MP0002006_tumorigenesis | 1.75040024 |
| 31 | MP0004947_skin_inflammation | 1.74978056 |
| 32 | MP0003436_decreased_susceptibility_to | 1.73588366 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.64199590 |
| 34 | MP0000383_abnormal_hair_follicle | 1.63751829 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.61650812 |
| 36 | * MP0002452_abnormal_antigen_presenting | 1.60714488 |
| 37 | MP0003303_peritoneal_inflammation | 1.59069444 |
| 38 | MP0003448_altered_tumor_morphology | 1.56244354 |
| 39 | MP0003329_amyloid_beta_deposits | 1.52669663 |
| 40 | * MP0001800_abnormal_humoral_immune | 1.49722946 |
| 41 | MP0010678_abnormal_skin_adnexa | 1.46411636 |
| 42 | MP0009840_abnormal_foam_cell | 1.41776396 |
| 43 | MP0009278_abnormal_bone_marrow | 1.41439745 |
| 44 | MP0000604_amyloidosis | 1.40961418 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.40178358 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.40178358 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.37355462 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.36540672 |
| 49 | * MP0001819_abnormal_immune_cell | 1.36297446 |
| 50 | MP0004270_analgesia | 1.36064612 |
| 51 | MP0003195_calcinosis | 1.35142622 |
| 52 | * MP0002420_abnormal_adaptive_immunity | 1.33517467 |
| 53 | MP0008004_abnormal_stomach_pH | 1.32049844 |
| 54 | * MP0001845_abnormal_inflammatory_respons | 1.30573891 |
| 55 | MP0003075_altered_response_to | 1.29119300 |
| 56 | * MP0008469_abnormal_protein_level | 1.28983664 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.27958213 |
| 58 | * MP0009765_abnormal_xenobiotic_induced | 1.24558136 |
| 59 | MP0002722_abnormal_immune_system | 1.24354311 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.23778450 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.23582471 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.23531792 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.20805458 |
| 64 | MP0001851_eye_inflammation | 1.19533404 |
| 65 | MP0001501_abnormal_sleep_pattern | 1.18931176 |
| 66 | MP0003634_abnormal_glial_cell | 1.16753653 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.11269719 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.11010158 |
| 69 | MP0004742_abnormal_vestibular_system | 1.10259618 |
| 70 | MP0001905_abnormal_dopamine_level | 1.09691246 |
| 71 | MP0002405_respiratory_system_inflammati | 1.05931502 |
| 72 | MP0005164_abnormal_response_to | 1.05696987 |
| 73 | MP0000858_altered_metastatic_potential | 1.03375616 |
| 74 | MP0001663_abnormal_digestive_system | 1.01386260 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.98699223 |
| 76 | MP0003632_abnormal_nervous_system | 0.95106626 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.94137843 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.91945768 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.90932996 |
| 80 | MP0005166_decreased_susceptibility_to | 0.90530211 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.90388946 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 0.90044655 |
| 83 | MP0001919_abnormal_reproductive_system | 0.88764195 |
| 84 | MP0003646_muscle_fatigue | 0.88677181 |
| 85 | * MP0000716_abnormal_immune_system | 0.88286062 |
| 86 | * MP0010155_abnormal_intestine_physiology | 0.87113081 |
| 87 | MP0004885_abnormal_endolymph | 0.83815356 |
| 88 | MP0003828_pulmonary_edema | 0.83672493 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.81215584 |
| 90 | MP0000613_abnormal_salivary_gland | 0.80012157 |
| 91 | MP0002734_abnormal_mechanical_nocicepti | 0.77585688 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.72067815 |
| 93 | MP0003866_abnormal_defecation | 0.72017580 |
| 94 | MP0000462_abnormal_digestive_system | 0.71511601 |
| 95 | MP0005390_skeleton_phenotype | 0.70241669 |
| 96 | MP0002933_joint_inflammation | 0.69292051 |
| 97 | MP0000343_altered_response_to | 0.69195294 |
| 98 | MP0010307_abnormal_tumor_latency | 0.69017408 |
| 99 | MP0008874_decreased_physiological_sensi | 0.68296695 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.67220781 |
| 101 | MP0001440_abnormal_grooming_behavior | 0.67105191 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 0.64865755 |
| 103 | MP0000470_abnormal_stomach_morphology | 0.64435187 |
| 104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64019946 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.63515346 |
| 106 | MP0005023_abnormal_wound_healing | 0.63441330 |
| 107 | MP0002733_abnormal_thermal_nociception | 0.62366166 |
| 108 | MP0000490_abnormal_crypts_of | 0.62121134 |
| 109 | MP0001873_stomach_inflammation | 0.61739410 |
| 110 | * MP0009763_increased_sensitivity_to | 0.61658596 |
| 111 | MP0005171_absent_coat_pigmentation | 0.60955810 |
| 112 | MP0005647_abnormal_sex_gland | 0.60217330 |
| 113 | MP0003091_abnormal_cell_migration | 0.59130143 |
| 114 | MP0001853_heart_inflammation | 0.58762177 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.58423045 |
| 116 | MP0001542_abnormal_bone_strength | 0.58232433 |
| 117 | MP0003045_fibrosis | 0.57965868 |
| 118 | MP0000778_abnormal_nervous_system | 0.57807191 |
| 119 | MP0005266_abnormal_metabolism | 0.57651458 |
| 120 | MP0000249_abnormal_blood_vessel | 0.57474953 |
| 121 | MP0005535_abnormal_body_temperature | 0.57432274 |
| 122 | * MP0002429_abnormal_blood_cell | 0.57312856 |
| 123 | * MP0002398_abnormal_bone_marrow | 0.57194588 |
| 124 | * MP0002019_abnormal_tumor_incidence | 0.56600209 |
| 125 | MP0002272_abnormal_nervous_system | 0.56571810 |
| 126 | MP0001881_abnormal_mammary_gland | 0.55975400 |
| 127 | MP0002693_abnormal_pancreas_physiology | 0.55960819 |
| 128 | MP0000609_abnormal_liver_physiology | 0.55632698 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.54000293 |
| 130 | MP0005381_digestive/alimentary_phenotyp | 0.53956957 |
| 131 | MP0003959_abnormal_lean_body | 0.53896665 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.53732409 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.53513063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 6.59747328 |
| 2 | Stomatitis (HP:0010280) | 5.01625638 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.79965648 |
| 4 | Optic neuritis (HP:0100653) | 4.79965648 |
| 5 | Sensory axonal neuropathy (HP:0003390) | 4.76514110 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.70461757 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 4.50976822 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.30870394 |
| 9 | T lymphocytopenia (HP:0005403) | 4.24549097 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.14144829 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.14144829 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.14144829 |
| 13 | Neurofibrillary tangles (HP:0002185) | 4.11723966 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.04375533 |
| 15 | Orchitis (HP:0100796) | 4.02769973 |
| 16 | Keratoconjunctivitis (HP:0001096) | 3.97025286 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.94711158 |
| 18 | Recurrent skin infections (HP:0001581) | 3.90785409 |
| 19 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.88177191 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.88177191 |
| 21 | Thick nail (HP:0001805) | 3.87259699 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.82459967 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 3.79954112 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 3.66579856 |
| 25 | IgG deficiency (HP:0004315) | 3.62453254 |
| 26 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.60574202 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57093456 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.55331177 |
| 29 | Gangrene (HP:0100758) | 3.52071897 |
| 30 | Prolonged neonatal jaundice (HP:0006579) | 3.50041538 |
| 31 | Myositis (HP:0100614) | 3.49624565 |
| 32 | Vasculitis (HP:0002633) | 3.43393508 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.40899234 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.27644086 |
| 35 | Fused cervical vertebrae (HP:0002949) | 3.27267799 |
| 36 | Akinesia (HP:0002304) | 3.22044743 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.18789244 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13235596 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13235596 |
| 40 | Recurrent viral infections (HP:0004429) | 3.12058722 |
| 41 | Amaurosis fugax (HP:0100576) | 3.09223072 |
| 42 | Xerostomia (HP:0000217) | 3.04703332 |
| 43 | Hypertensive crisis (HP:0100735) | 3.02594729 |
| 44 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.95491557 |
| 45 | IgA deficiency (HP:0002720) | 2.91349836 |
| 46 | Increased IgM level (HP:0003496) | 2.90051123 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.86799736 |
| 48 | Increased serum ferritin (HP:0003281) | 2.86256622 |
| 49 | Abnormality of T cells (HP:0002843) | 2.84635962 |
| 50 | Stenosis of the external auditory canal (HP:0000402) | 2.81597349 |
| 51 | Purpura (HP:0000979) | 2.77364676 |
| 52 | Abnormality of the corticospinal tract (HP:0002492) | 2.76838774 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.76628557 |
| 54 | Cerebral hemorrhage (HP:0001342) | 2.71772794 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.71347158 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.67630559 |
| 57 | Meningitis (HP:0001287) | 2.64715241 |
| 58 | Conical tooth (HP:0000698) | 2.63891677 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.59809746 |
| 60 | Chronic diarrhea (HP:0002028) | 2.59481119 |
| 61 | Colitis (HP:0002583) | 2.59442527 |
| 62 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.56906194 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.54623669 |
| 64 | Severe combined immunodeficiency (HP:0004430) | 2.53767902 |
| 65 | Obstructive lung disease (HP:0006536) | 2.52955149 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.52955149 |
| 67 | Abnormality of B cell number (HP:0010975) | 2.52596147 |
| 68 | Loss of speech (HP:0002371) | 2.52205910 |
| 69 | Hemoptysis (HP:0002105) | 2.51797296 |
| 70 | B lymphocytopenia (HP:0010976) | 2.51001996 |
| 71 | Nausea (HP:0002018) | 2.48843702 |
| 72 | Thin bony cortex (HP:0002753) | 2.47981750 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.47850565 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.47796846 |
| 75 | Joint swelling (HP:0001386) | 2.46812574 |
| 76 | Recurrent fungal infections (HP:0002841) | 2.44488571 |
| 77 | Chest pain (HP:0100749) | 2.43131668 |
| 78 | Gingivitis (HP:0000230) | 2.40964000 |
| 79 | Asplenia (HP:0001746) | 2.40731078 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 2.40572175 |
| 81 | Onion bulb formation (HP:0003383) | 2.40360907 |
| 82 | Spastic paraparesis (HP:0002313) | 2.38987201 |
| 83 | Abnormality of the endocardium (HP:0004306) | 2.37484147 |
| 84 | Erythroderma (HP:0001019) | 2.37136099 |
| 85 | Nuclear cataract (HP:0100018) | 2.36748909 |
| 86 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.36662475 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.35983396 |
| 88 | Flat occiput (HP:0005469) | 2.35798727 |
| 89 | Alacrima (HP:0000522) | 2.33791053 |
| 90 | Small epiphyses (HP:0010585) | 2.32186307 |
| 91 | Gastrointestinal inflammation (HP:0004386) | 2.32110720 |
| 92 | Polyneuropathy (HP:0001271) | 2.31032720 |
| 93 | Arterial thrombosis (HP:0004420) | 2.30844873 |
| 94 | Supranuclear gaze palsy (HP:0000605) | 2.30343212 |
| 95 | Double outlet right ventricle (HP:0001719) | 2.30183822 |
| 96 | Congenital malformation of the right heart (HP:0011723) | 2.30183822 |
| 97 | Generalized aminoaciduria (HP:0002909) | 2.28810591 |
| 98 | Absent hand (HP:0004050) | 2.28373842 |
| 99 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.27041928 |
| 100 | Cerebral hypomyelination (HP:0006808) | 2.24787853 |
| 101 | Disinhibition (HP:0000734) | 2.23547804 |
| 102 | Decreased subcutaneous fat (HP:0001002) | 2.22001800 |
| 103 | Granulocytopenia (HP:0001913) | 2.20530014 |
| 104 | Metaphyseal irregularity (HP:0003025) | 2.18941545 |
| 105 | Pulmonary infiltrates (HP:0002113) | 2.17991491 |
| 106 | Peripheral hypomyelination (HP:0007182) | 2.17608237 |
| 107 | Recurrent pneumonia (HP:0006532) | 2.13404361 |
| 108 | Abnormality of the pleura (HP:0002103) | 2.13061242 |
| 109 | Slow saccadic eye movements (HP:0000514) | 2.12353353 |
| 110 | Enlarged epiphyses (HP:0010580) | 2.12133075 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11706701 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.11073476 |
| 113 | Glomerulopathy (HP:0100820) | 2.08695893 |
| 114 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.07646018 |
| 115 | Hematochezia (HP:0002573) | 2.07405590 |
| 116 | Cellulitis (HP:0100658) | 2.06583164 |
| 117 | Lymphopenia (HP:0001888) | 2.06312583 |
| 118 | Systemic lupus erythematosus (HP:0002725) | 2.05635813 |
| 119 | Increased IgE level (HP:0003212) | 2.05505191 |
| 120 | Acne (HP:0001061) | 2.03372760 |
| 121 | Petechiae (HP:0000967) | 2.02839910 |
| 122 | Delayed epiphyseal ossification (HP:0002663) | 2.01962284 |
| 123 | Abnormality of eosinophils (HP:0001879) | 2.00126322 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.98231686 |
| 125 | Respiratory distress (HP:0002098) | 1.98224092 |
| 126 | Increased circulating renin level (HP:0000848) | 1.97141222 |
| 127 | Urticaria (HP:0001025) | 1.96612184 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94945644 |
| 129 | Cupped ear (HP:0000378) | 1.94926682 |
| 130 | Neoplasm of head and neck (HP:0012288) | 1.94202012 |
| 131 | Esophageal neoplasm (HP:0100751) | 1.94202012 |
| 132 | Recurrent bronchitis (HP:0002837) | 1.94060954 |
| 133 | Paraparesis (HP:0002385) | 1.92262851 |
| 134 | Leukocytosis (HP:0001974) | 1.91830714 |
| 135 | Anorexia (HP:0002039) | 1.91540708 |
| 136 | Oral leukoplakia (HP:0002745) | 1.91333748 |
| 137 | Diminished movement (HP:0002374) | 1.90326605 |
| 138 | Premature skin wrinkling (HP:0100678) | 1.89457030 |
| 139 | Chronic otitis media (HP:0000389) | 1.89089635 |
| 140 | Pustule (HP:0200039) | 1.87905011 |
| 141 | Hyperphosphatemia (HP:0002905) | 1.87577796 |
| 142 | Spastic gait (HP:0002064) | 1.84301110 |
| 143 | Depressed nasal tip (HP:0000437) | 1.82856339 |
| 144 | Encephalitis (HP:0002383) | 1.82597842 |
| 145 | Pulmonary embolism (HP:0002204) | 1.78337395 |
| 146 | Intention tremor (HP:0002080) | 1.77516432 |
| 147 | Anomalous pulmonary venous return (HP:0010772) | 1.76433394 |
| 148 | Septo-optic dysplasia (HP:0100842) | 1.75417740 |
| 149 | Arthralgia (HP:0002829) | 1.75128956 |
| 150 | Cone-rod dystrophy (HP:0000548) | 1.74271826 |
| 151 | Absent septum pellucidum (HP:0001331) | 1.73890257 |
| 152 | Esophageal atresia (HP:0002032) | 1.73722651 |
| 153 | Abnormality of proline metabolism (HP:0010907) | 1.73110003 |
| 154 | Hydroxyprolinuria (HP:0003080) | 1.73110003 |
| 155 | Keratitis (HP:0000491) | 1.72866411 |
| 156 | Basal ganglia calcification (HP:0002135) | 1.70785108 |
| 157 | Eosinophilia (HP:0001880) | 1.70211459 |
| 158 | Abnormal auditory evoked potentials (HP:0006958) | 1.69151255 |
| 159 | Porencephaly (HP:0002132) | 1.68970900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.32993557 |
| 2 | EPHB1 | 4.08932718 |
| 3 | MAP3K14 | 4.08830669 |
| 4 | TNIK | 3.44681439 |
| 5 | MST4 | 3.37582322 |
| 6 | OXSR1 | 3.14699843 |
| 7 | BCR | 2.81179174 |
| 8 | IRAK3 | 2.81164451 |
| 9 | TAOK2 | 2.65584113 |
| 10 | IRAK4 | 2.62431044 |
| 11 | TBK1 | 2.40208661 |
| 12 | FGR | 2.38226836 |
| 13 | NME2 | 2.38073551 |
| 14 | WNK4 | 2.36365519 |
| 15 | PBK | 2.23927271 |
| 16 | TXK | 2.15183619 |
| 17 | IKBKB | 2.10814619 |
| 18 | ERN1 | 2.06151707 |
| 19 | MATK | 2.04825326 |
| 20 | BLK | 1.88824782 |
| 21 | IKBKE | 1.73838712 |
| 22 | ADRBK2 | 1.70317434 |
| 23 | MAP3K13 | 1.69531570 |
| 24 | PKN1 | 1.69257410 |
| 25 | ARAF | 1.66694293 |
| 26 | ICK | 1.62100448 |
| 27 | ERBB4 | 1.59393857 |
| 28 | MET | 1.58213452 |
| 29 | CDK19 | 1.56890297 |
| 30 | BMPR2 | 1.49757234 |
| 31 | EPHA3 | 1.49324174 |
| 32 | TAOK3 | 1.43886577 |
| 33 | DDR2 | 1.43664071 |
| 34 | MARK3 | 1.43303547 |
| 35 | MAP3K11 | 1.31723669 |
| 36 | IRAK1 | 1.30437278 |
| 37 | ZAP70 | 1.29680446 |
| 38 | MAP3K3 | 1.28435432 |
| 39 | CHUK | 1.28279464 |
| 40 | CSK | 1.25398277 |
| 41 | WNK1 | 1.20380799 |
| 42 | PIM1 | 1.16752480 |
| 43 | JAK3 | 1.15980786 |
| 44 | KSR2 | 1.12892552 |
| 45 | TAOK1 | 1.11508076 |
| 46 | PRKCQ | 1.07991094 |
| 47 | BTK | 1.06069731 |
| 48 | CLK1 | 1.05463892 |
| 49 | NTRK1 | 1.03837197 |
| 50 | RIPK1 | 1.03021446 |
| 51 | SIK3 | 1.01572009 |
| 52 | FGFR2 | 0.99404221 |
| 53 | MAP3K1 | 0.99071743 |
| 54 | TEC | 0.97427172 |
| 55 | ROCK2 | 0.96275792 |
| 56 | MAP3K9 | 0.95187210 |
| 57 | MAP2K3 | 0.93789091 |
| 58 | LIMK1 | 0.93090735 |
| 59 | NUAK1 | 0.91418698 |
| 60 | IRAK2 | 0.90011561 |
| 61 | MAP4K1 | 0.89858713 |
| 62 | NLK | 0.87603629 |
| 63 | MAP3K5 | 0.87197856 |
| 64 | PRPF4B | 0.87011086 |
| 65 | NEK6 | 0.86299981 |
| 66 | PIM2 | 0.83936441 |
| 67 | CSNK1A1L | 0.81197370 |
| 68 | CDC42BPA | 0.79877126 |
| 69 | BMPR1B | 0.79653927 |
| 70 | UHMK1 | 0.78278181 |
| 71 | MELK | 0.78268850 |
| 72 | GRK7 | 0.77037738 |
| 73 | PAK6 | 0.75514521 |
| 74 | CSNK1G3 | 0.74463161 |
| 75 | STK10 | 0.71722538 |
| 76 | EPHA2 | 0.67496278 |
| 77 | SIK2 | 0.67355291 |
| 78 | FYN | 0.61298165 |
| 79 | EPHB2 | 0.61187733 |
| 80 | EIF2AK2 | 0.59389689 |
| 81 | BMX | 0.59187525 |
| 82 | LYN | 0.57770706 |
| 83 | ABL1 | 0.56575635 |
| 84 | ABL2 | 0.56098104 |
| 85 | PRKCD | 0.54865488 |
| 86 | LCK | 0.53928229 |
| 87 | RAF1 | 0.52260109 |
| 88 | CAMK2D | 0.49615029 |
| 89 | PRKCE | 0.48441078 |
| 90 | MAPK11 | 0.47462346 |
| 91 | MAPKAPK5 | 0.46981317 |
| 92 | JAK2 | 0.46387037 |
| 93 | ITK | 0.46001216 |
| 94 | CSNK1G1 | 0.45849428 |
| 95 | HIPK2 | 0.43347797 |
| 96 | BRAF | 0.42621864 |
| 97 | PAK3 | 0.42253939 |
| 98 | RIPK4 | 0.42240241 |
| 99 | CSF1R | 0.41144684 |
| 100 | HCK | 0.39977765 |
| 101 | MAP3K8 | 0.39892699 |
| 102 | TGFBR2 | 0.39791307 |
| 103 | PDK1 | 0.39635205 |
| 104 | CDK4 | 0.39171386 |
| 105 | BCKDK | 0.38868924 |
| 106 | MAP2K6 | 0.37853090 |
| 107 | CDK14 | 0.37414294 |
| 108 | KSR1 | 0.37074319 |
| 109 | DYRK2 | 0.36490219 |
| 110 | TESK2 | 0.36048830 |
| 111 | CAMK2B | 0.35494908 |
| 112 | RPS6KA5 | 0.35200660 |
| 113 | MOS | 0.35061831 |
| 114 | EIF2AK3 | 0.34041917 |
| 115 | TYRO3 | 0.33900664 |
| 116 | JAK1 | 0.33876773 |
| 117 | STK3 | 0.33329199 |
| 118 | TYK2 | 0.33193178 |
| 119 | DYRK1B | 0.33090201 |
| 120 | PDK2 | 0.32566805 |
| 121 | STK11 | 0.32563024 |
| 122 | FGFR4 | 0.32047171 |
| 123 | FES | 0.32009198 |
| 124 | MAPK4 | 0.31635131 |
| 125 | ADRBK1 | 0.31496833 |
| 126 | CSNK1G2 | 0.31088053 |
| 127 | INSR | 0.29795032 |
| 128 | TLK1 | 0.29230825 |
| 129 | LRRK2 | 0.28582264 |
| 130 | PTK6 | 0.28129845 |
| 131 | TRPM7 | 0.28125781 |
| 132 | GRK6 | 0.28120707 |
| 133 | EGFR | 0.27424641 |
| 134 | PRKCG | 0.27311441 |
| 135 | CSNK1D | 0.26519648 |
| 136 | CAMK2A | 0.25760693 |
| 137 | CSNK1A1 | 0.24290511 |
| 138 | MAPKAPK2 | 0.23406693 |
| 139 | TNK2 | 0.22638049 |
| 140 | SYK | 0.22312465 |
| 141 | CDK5 | 0.21833427 |
| 142 | MST1R | 0.21433471 |
| 143 | PAK1 | 0.20895329 |
| 144 | CDK6 | 0.18320477 |
| 145 | MAPK3 | 0.18126441 |
| 146 | FGFR3 | 0.17380493 |
| 147 | RPS6KA1 | 0.15740485 |
| 148 | PDPK1 | 0.15487928 |
| 149 | DYRK3 | 0.14511101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.30650120 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.23218266 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.19578497 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.88947821 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.75901222 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.67110970 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.65522922 |
| 8 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.64272757 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.63650760 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.62430153 |
| 11 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44227242 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43973538 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.41681169 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.32484306 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.30585008 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.28170534 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.19648980 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.17134705 |
| 19 | Salmonella infection_Homo sapiens_hsa05132 | 2.02395195 |
| 20 | * Pertussis_Homo sapiens_hsa05133 | 1.82004931 |
| 21 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.70379006 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.55383428 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.51664121 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51224128 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47991059 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46402228 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45117953 |
| 28 | * Tuberculosis_Homo sapiens_hsa05152 | 1.43477254 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41453949 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34327223 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32231527 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32038054 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.15703839 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15396545 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.15299122 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13608538 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11543023 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07878730 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05946518 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04689121 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 0.97022906 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91746293 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91532689 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90163512 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84989622 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 0.83638062 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.78533979 |
| 48 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77196997 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75207335 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74135366 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.70726880 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70333999 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 0.69316756 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68494671 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66942863 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65084524 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61729551 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57583774 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57506886 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56569405 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55311214 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54458042 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53887164 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.53672281 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53496187 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53478699 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.52213674 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51781132 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51311180 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50977106 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50903787 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47310509 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46296495 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44815366 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44558671 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44411637 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43644378 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.41585849 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41120169 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40961688 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.40774802 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40431729 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.39558414 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39232175 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38001147 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37125901 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35408764 |
| 88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34691764 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34503220 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32690806 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.32435691 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31614512 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30283414 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30089271 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29610987 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29471561 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29165536 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28152175 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.27203359 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26727697 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25325735 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.24688826 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24598259 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.22589754 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22087245 |
| 106 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.21475361 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21352255 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21238030 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.20316854 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18406373 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17672556 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16242114 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.15969070 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14850421 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13845623 |
| 116 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.13760089 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.13141641 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.12378322 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.11033432 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.10805539 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10247375 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09992768 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09727460 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.09568853 |
| 125 | Ribosome_Homo sapiens_hsa03010 | 0.08760330 |
| 126 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.08028748 |
| 127 | Basal transcription factors_Homo sapiens_hsa03022 | 0.07021384 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.06963860 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.06788146 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.04968406 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.04882790 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01567293 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.00910027 |
| 134 | Homologous recombination_Homo sapiens_hsa03440 | -0.0066637 |

